tiprankstipranks
Bristol-Myers Squibb (DE:BRM)
XETRA:BRM

Compare Bristol-Myers Squibb (BRM) vs. Competitors

19 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Bristol-Myers Squibb
€49.41
€101.77B
15.61
13.00%
7 Buy
12 Hold
1 Sell
Moderate Buy
Amgen
$349.82
$189.22B
22.84
22.32%
12 Buy
10 Hold
1 Sell
Moderate Buy
Gilead Sciences
$139.03
$172.52B
17.94
34.16%
17 Buy
5 Hold
0 Sell
Strong Buy
GlaxoSmithKline
$58.94
$117.44B
28.75
70.15%
0 Buy
3 Hold
0 Sell
Hold
Merck & Company
$120.15
$300.20B
14.46
51.74%
13 Buy
7 Hold
0 Sell
Moderate Buy
Pfizer
$27.34
$153.13B
18.21
24.78%
8 Buy
13 Hold
2 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:BRM
Bristol-Myers Squibb
49.41
7.18
16.99%
AMGN
Amgen
349.82
63.50
22.18%
GILD
Gilead Sciences
139.03
36.09
35.06%
GSK
GlaxoSmithKline
58.94
24.63
71.77%
MRK
Merck & Company
120.15
44.51
58.84%
PFE
Pfizer
27.34
6.42
30.68%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts